Septerna (SEPN) shares sank 59% amid heavy trading after the company said Tuesday it discontinued a phase 1 clinical trial of SEP-786 to treat hypoparathyroidism in healthy volunteers.
Intraday trading volume soared to nearly 6.27 million shares from a daily average of about 313,000.
Greenlane Holdings (GNLN) said Tuesday it struck deals to sell about $25.0 million of shares and investor warrants at $1.19 per unit to institutional investors.
Shares sank 37%, with intraday trading volume catapulting to over 2.92 million versus a daily average of about 122,000.
Medtronic (MDT) reported fiscal Q3 revenue below analyst projections as some distributors cut surgical inventory levels, weighing on the division's performance.
Shares slid 6.5% as intraday trading volume rose to over 8.32 million from the stock's daily average of about 6.7 million.
Price: 5.37, Change: -7.59, Percent Change: -58.56
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。